Earnings Call · Q1 FY2026·2026-05-08

Q1 26EPS +93.18%·Rev n/aQ4 25EPS -100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +22.43%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Ellen Cavaleri — Head of Investor Relations

Matthew Klein — CHIEF EXECUTIVE OFFICER

Eric Pauwels — CHIEF BUSINESS OFFICER

Pierre Gravier — CHIEF FINANCIAL OFFICER

+14.3%1d on move date+13.4% vs SPY3d+16.3%5d+12.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access